A phase II study of single agent paclitaxel in patients at first relapse following initial chemotherapy for breast cancer
Authors:
- 31 December 1996
- journal article
- clinical trial
- Published by Elsevier in Clinical Oncology
- Vol. 8 (6) , 358-362
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Epirubicin chemotherapy and advanced breast cancer after adjuvant CMF chemotherapyClinical Oncology, 1995
- A phase II trial with Docetaxel (Taxotere™) in second line treatment with chemotherapy for advanced breast cancerAnnals of Oncology, 1994
- Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapyCancer, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI: Journal of the National Cancer Institute, 1991
- Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.Journal of Clinical Oncology, 1991
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961